Consuelo Bertossi, MD, discusses centralized academic reference diagnostics and biobanking in prospective, multicenter clinical trials.
Consuelo Bertossi, MD
Advertisement
Articles by Consuelo Bertossi, MD
Consuelo Bertossi, MD, discusses the role of TP53 mutations and their prognostic significance in chronic lymphocytic leukemia.
Advertisement
Latest Updated Articles
Dr Bertossi on the Role of Centralized Academic Reference Diagnostics and Biobanking in Clinical TrialsPublished: August 14th 2024 | Updated:
Dr Bertossi on the Prognostic Role of TP53 Mutations in CLLPublished: June 15th 2024 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
4
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
5